Copyright Reports & Markets. All rights reserved.

Global In-Silico Drug Discovery Market Size, Status and Forecast 2020-2026

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by In-Silico Drug Discovery Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global In-Silico Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Software as a Service
      • 1.4.3 Consultancy as a Service
    • 1.5 Market by Application
      • 1.5.1 Global In-Silico Drug Discovery Market Share by Application: 2020 VS 2026
      • 1.5.2 Contract Research Organization
      • 1.5.3 Pharmaceutical Industry
      • 1.5.4 Academic and Research Institutes
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 In-Silico Drug Discovery Market Perspective (2015-2026)
    • 2.2 In-Silico Drug Discovery Growth Trends by Regions
      • 2.2.1 In-Silico Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 In-Silico Drug Discovery Historic Market Share by Regions (2015-2020)
      • 2.2.3 In-Silico Drug Discovery Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 In-Silico Drug Discovery Market Growth Strategy
      • 2.3.6 Primary Interviews with Key In-Silico Drug Discovery Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top In-Silico Drug Discovery Players by Market Size
      • 3.1.1 Global Top In-Silico Drug Discovery Players by Revenue (2015-2020)
      • 3.1.2 Global In-Silico Drug Discovery Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global In-Silico Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global In-Silico Drug Discovery Market Concentration Ratio
      • 3.2.1 Global In-Silico Drug Discovery Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by In-Silico Drug Discovery Revenue in 2019
    • 3.3 In-Silico Drug Discovery Key Players Head office and Area Served
    • 3.4 Key Players In-Silico Drug Discovery Product Solution and Service
    • 3.5 Date of Enter into In-Silico Drug Discovery Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global In-Silico Drug Discovery Historic Market Size by Type (2015-2020)
    • 4.2 Global In-Silico Drug Discovery Forecasted Market Size by Type (2021-2026)

    5 In-Silico Drug Discovery Breakdown Data by Application (2015-2026)

    • 5.1 Global In-Silico Drug Discovery Market Size by Application (2015-2020)
    • 5.2 Global In-Silico Drug Discovery Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America In-Silico Drug Discovery Market Size (2015-2020)
    • 6.2 In-Silico Drug Discovery Key Players in North America (2019-2020)
    • 6.3 North America In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 6.4 North America In-Silico Drug Discovery Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe In-Silico Drug Discovery Market Size (2015-2020)
    • 7.2 In-Silico Drug Discovery Key Players in Europe (2019-2020)
    • 7.3 Europe In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 7.4 Europe In-Silico Drug Discovery Market Size by Application (2015-2020)

    8 China

    • 8.1 China In-Silico Drug Discovery Market Size (2015-2020)
    • 8.2 In-Silico Drug Discovery Key Players in China (2019-2020)
    • 8.3 China In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 8.4 China In-Silico Drug Discovery Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan In-Silico Drug Discovery Market Size (2015-2020)
    • 9.2 In-Silico Drug Discovery Key Players in Japan (2019-2020)
    • 9.3 Japan In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 9.4 Japan In-Silico Drug Discovery Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia In-Silico Drug Discovery Market Size (2015-2020)
    • 10.2 In-Silico Drug Discovery Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 10.4 Southeast Asia In-Silico Drug Discovery Market Size by Application (2015-2020)

    11 India

    • 11.1 India In-Silico Drug Discovery Market Size (2015-2020)
    • 11.2 In-Silico Drug Discovery Key Players in India (2019-2020)
    • 11.3 India In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 11.4 India In-Silico Drug Discovery Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America In-Silico Drug Discovery Market Size (2015-2020)
    • 12.2 In-Silico Drug Discovery Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America In-Silico Drug Discovery Market Size by Type (2015-2020)
    • 12.4 Central & South America In-Silico Drug Discovery Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Albany Molecular Research
      • 13.1.1 Albany Molecular Research Company Details
      • 13.1.2 Albany Molecular Research Business Overview and Its Total Revenue
      • 13.1.3 Albany Molecular Research In-Silico Drug Discovery Introduction
      • 13.1.4 Albany Molecular Research Revenue in In-Silico Drug Discovery Business (2015-2020))
      • 13.1.5 Albany Molecular Research Recent Development
    • 13.2 Certara USA
      • 13.2.1 Certara USA Company Details
      • 13.2.2 Certara USA Business Overview and Its Total Revenue
      • 13.2.3 Certara USA In-Silico Drug Discovery Introduction
      • 13.2.4 Certara USA Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.2.5 Certara USA Recent Development
    • 13.3 Charles River
      • 13.3.1 Charles River Company Details
      • 13.3.2 Charles River Business Overview and Its Total Revenue
      • 13.3.3 Charles River In-Silico Drug Discovery Introduction
      • 13.3.4 Charles River Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.3.5 Charles River Recent Development
    • 13.4 Evotec
      • 13.4.1 Evotec Company Details
      • 13.4.2 Evotec Business Overview and Its Total Revenue
      • 13.4.3 Evotec In-Silico Drug Discovery Introduction
      • 13.4.4 Evotec Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.4.5 Evotec Recent Development
    • 13.5 GVK Biosciences
      • 13.5.1 GVK Biosciences Company Details
      • 13.5.2 GVK Biosciences Business Overview and Its Total Revenue
      • 13.5.3 GVK Biosciences In-Silico Drug Discovery Introduction
      • 13.5.4 GVK Biosciences Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.5.5 GVK Biosciences Recent Development
    • 13.6 ICAGEN
      • 13.6.1 ICAGEN Company Details
      • 13.6.2 ICAGEN Business Overview and Its Total Revenue
      • 13.6.3 ICAGEN In-Silico Drug Discovery Introduction
      • 13.6.4 ICAGEN Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.6.5 ICAGEN Recent Development
    • 13.7 Numerate
      • 13.7.1 Numerate Company Details
      • 13.7.2 Numerate Business Overview and Its Total Revenue
      • 13.7.3 Numerate In-Silico Drug Discovery Introduction
      • 13.7.4 Numerate Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.7.5 Numerate Recent Development
    • 13.8 Schrodinger
      • 13.8.1 Schrodinger Company Details
      • 13.8.2 Schrodinger Business Overview and Its Total Revenue
      • 13.8.3 Schrodinger In-Silico Drug Discovery Introduction
      • 13.8.4 Schrodinger Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.8.5 Schrodinger Recent Development
    • 13.9 Selvita
      • 13.9.1 Selvita Company Details
      • 13.9.2 Selvita Business Overview and Its Total Revenue
      • 13.9.3 Selvita In-Silico Drug Discovery Introduction
      • 13.9.4 Selvita Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.9.5 Selvita Recent Development
    • 13.10 WuXi AppTec
      • 13.10.1 WuXi AppTec Company Details
      • 13.10.2 WuXi AppTec Business Overview and Its Total Revenue
      • 13.10.3 WuXi AppTec In-Silico Drug Discovery Introduction
      • 13.10.4 WuXi AppTec Revenue in In-Silico Drug Discovery Business (2015-2020)
      • 13.10.5 WuXi AppTec Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global In-Silico Drug Discovery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In-Silico Drug Discovery development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Albany Molecular Research
      Certara USA
      Charles River
      Evotec
      GVK Biosciences
      ICAGEN
      Numerate
      Schrodinger
      Selvita
      WuXi AppTec

      Market segment by Type, the product can be split into
      Software as a Service
      Consultancy as a Service
      Market segment by Application, split into
      Contract Research Organization
      Pharmaceutical Industry
      Academic and Research Institutes
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global In-Silico Drug Discovery status, future forecast, growth opportunity, key market and key players.
      To present the In-Silico Drug Discovery development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of In-Silico Drug Discovery are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now